Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexarotene and Fenretinide in Schizophrenia
NCT00534898Phase 3Withdrawn
- Sponsor
- Be'er Sheva Mental Health Center
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bexarotene, fenretinide in schizophrenia, schizoaffective disorder, sponsored by Be'er Sheva Mental Health Center. Status: withdrawn.
02
Drugs
bexarotenefenretinide
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00534898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00534898.